Hydrochloric Acid → HCID 178432911, 화합물
반응식
[Br:1][C:2]1[N:3]=[C:4]([C@H:12]2[CH2:17][CH2:16][C@H:15]([N:18]3[CH2:23][CH2:22][N:21](C(=O)C)[CH2:20][CH2:19]3)[CH2:14][CH2:13]2)[N:5]2[CH:10]=[CH:9][N:8]=[C:7]([CH3:11])[C:6]=12.[ClH:27]>C(O)C>[ClH:27].[Br:1][C:2]1[N:3]=[C:4]([C@H:12]2[CH2:13][CH2:14][C@H:15]([N:18]3[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]3)[CH2:16][CH2:17]2)[N:5]2[CH:10]=[CH:9][N:8]=[C:7]([CH3:11])[C:6]=12참가 물질
4
실험 절차
To 1-(4-((trans)-4-(1-bromo-8-methylimidazo[1,5-a]pyrazin-3-yl)cyclohexyl)piperazin-1-yl)ethanone (0.108 mmol, 45.4 mg) in ethanol was added 2 M hydrochloric acid (4.32 mmol, 2.16 ml) and stirred at reflux for four hours. The reaction mixture was cooled, concentrated in vacuo, coevaporated with toluene twice and washed with dichloromethane twice to give 1-bromo-8-methyl-3-((trans)-4-(piperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazine hydrochloride (56 mg) product which was used without further purification.